Called Prism and Sentinel, the programs aim unlock precision insights and powerful innovation in clinical development, commercial strategy, HEOR, and beyond.
The company plans to use the funds to continue expanding its customer base and enhancing its data visualizations and advanced analytics.
With this additional funding, the company will extend the capabilities of its platform, as well as expand and commercialize its solutions.
The company will use the funds to expand the reach of its data-driven programs beyond Southeast Asia.
The strategic partnership aims to help hospitals and health systems improve patient access, clinical outcomes and financial performance.
The agreement utilizes Inovalon and Avalere's combined breadth of healthcare capabilities and integrated platform supporting greater data integration and analytics.